effects of glp 1 Adverse GLP-1 class drugs. Gastrointestinal issues are Exploring the Side Effects of

95% CI, 1.00 to 1.77) exhibited a significantly elevated risk, whereas dulaglutide did not

A network meta-analyses put tirzepatide clearly ahead on weight loss, which is the expected outcome for a dual GLP-1/GIP agonist versus a single GLP-1 agonist

For tirzepatide pens, the same standard applies

This regimen may pose adherence challenges for some, while others may appreciate the convenience of avoiding injections altogether

Why Hair Loss Happens After GLP-1 Medications Many people using weight-loss medications notice increased shedding a few weeks or months after starting treatment

That contributes to higher drug costs